165 related articles for article (PubMed ID: 17918257)
1. Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors.
Möller E; Mandahl N; Mertens F; Panagopoulos I
Genes Chromosomes Cancer; 2008 Jan; 47(1):21-5. PubMed ID: 17918257
[TBL] [Abstract][Full Text] [Related]
2. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
West RB; Rubin BP; Miller MA; Subramanian S; Kaygusuz G; Montgomery K; Zhu S; Marinelli RJ; De Luca A; Downs-Kelly E; Goldblum JR; Corless CL; Brown PO; Gilks CB; Nielsen TO; Huntsman D; van de Rijn M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):690-5. PubMed ID: 16407111
[TBL] [Abstract][Full Text] [Related]
3. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation.
Huang HY; West RB; Tzeng CC; van de Rijn M; Wang JW; Chou SC; Huang WW; Eng HL; Lin CN; Yu SC; Wu JM; Lu CC; Li CF
Clin Cancer Res; 2008 Oct; 14(19):6023-32. PubMed ID: 18829481
[TBL] [Abstract][Full Text] [Related]
5. Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors.
Panagopoulos I; Brandal P; Gorunova L; Bjerkehagen B; Heim S
Int J Oncol; 2014 May; 44(5):1425-32. PubMed ID: 24604026
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.
Fiocco U; Sfriso P; Lunardi F; Pagnin E; Oliviero F; Scagliori E; Cozzi L; Vezzù M; Molena B; Scanu A; Panziera C; Nardacchione R; Rubaltelli L; Dayer JM; Calabrese F; Punzi L
Autoimmun Rev; 2010 Sep; 9(11):780-4. PubMed ID: 20620241
[TBL] [Abstract][Full Text] [Related]
7. Intramuscular Tenosynovial Giant Cell Tumor Harboring a Novel
Mejbel H; Siegal GP; Wei S
Int J Surg Pathol; 2022 May; 30(3):335-338. PubMed ID: 34657489
[TBL] [Abstract][Full Text] [Related]
8. Detection of CSF1 rearrangements deleting the 3' UTR in tenosynovial giant cell tumors.
Ho J; Peters T; Dickson BC; Swanson D; Fernandez A; Frova-Seguin A; Valentin MA; Schramm U; Sultan M; Nielsen TO; Demicco EG
Genes Chromosomes Cancer; 2020 Feb; 59(2):96-105. PubMed ID: 31469468
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors.
Nilsson M; Höglund M; Panagopoulos I; Sciot R; Dal Cin P; Debiec-Rychter M; Mertens F; Mandahl N
Virchows Arch; 2002 Nov; 441(5):475-80. PubMed ID: 12447678
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic characterization of tenosynovial giant cell tumors (nodular tenosynovitis).
Dal Cin P; Sciot R; Samson I; De Smet L; De Wever I; Van Damme B; Van den Berghe H
Cancer Res; 1994 Aug; 54(15):3986-7. PubMed ID: 8033128
[TBL] [Abstract][Full Text] [Related]
11. Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations.
Tsuda Y; Hirata M; Katayama K; Motoi T; Matsubara D; Oda Y; Fujita M; Kobayashi H; Kawano H; Nishida Y; Sakai T; Okuma T; Goto T; Ogura K; Kawai A; Ae K; Anazawa U; Suehara Y; Iwata S; Miyano S; Imoto S; Shibata T; Nakagawa H; Yamaguchi R; Tanaka S; Matsuda K
Int J Cancer; 2019 Dec; 145(12):3276-3284. PubMed ID: 31107544
[TBL] [Abstract][Full Text] [Related]
12. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.
O'Brien KP; Seroussi E; Dal Cin P; Sciot R; Mandahl N; Fletcher JA; Turc-Carel C; Dumanski JP
Genes Chromosomes Cancer; 1998 Oct; 23(2):187-93. PubMed ID: 9739023
[TBL] [Abstract][Full Text] [Related]
13. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
Chinen Y; Taki T; Nishida K; Shimizu D; Okuda T; Yoshida N; Kobayashi C; Koike K; Tsuchida M; Hayashi Y; Taniwaki M
Oncogene; 2008 Apr; 27(15):2249-56. PubMed ID: 17968322
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
[TBL] [Abstract][Full Text] [Related]
15. Diffuse-type tenosynovial giant cell tumor with t(1;17)(p13;p13) and trisomy 5.
Nishio J; Kamachi Y; Iwasaki H; Naito M
In Vivo; 2014; 28(5):949-52. PubMed ID: 25189912
[TBL] [Abstract][Full Text] [Related]
16. A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor.
Lipplaa A; Meijer D; van de Sande MAJ; Gelderblom H; Bovée JVMG; Mei H; Szuhai K
Genes Chromosomes Cancer; 2023 Apr; 62(4):223-230. PubMed ID: 36504457
[TBL] [Abstract][Full Text] [Related]
17. Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene.
Brahmi M; Alberti L; Tirode F; Karanian M; Eberst L; Pissaloux D; Cassier P; Blay JY
Ann Oncol; 2018 Jun; 29(6):1488-1489. PubMed ID: 29668829
[No Abstract] [Full Text] [Related]
18. Establishment and characterization of a novel cell line, NCC-TGCT1-C1, derived from a patient with tenosynovial giant cell tumor.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Jan; 34(1):254-259. PubMed ID: 32886306
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Shimizu J; Murahashi Y; Emori M; Hasegawa T
Diagn Pathol; 2022 Nov; 17(1):88. PubMed ID: 36320082
[TBL] [Abstract][Full Text] [Related]
20. Molecular Profiling of Atypical Tenosynovial Giant Cell Tumors Reveals Novel Non-
Vougiouklakis T; Shen G; Feng X; Hoda ST; Jour G
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31906059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
